Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1CALAN SR

02 1CIMETIDINE

03 1CYCLOBENZAPRINE HYDROCHLORIDE

04 1DIABETA

05 1DICLOFENAC SODIUM

06 1DONEPEZIL HYDROCHLORIDE

07 1FLUPHENAZINE HYDROCHLORIDE

08 2GLYBURIDE

09 3GRISEOFULVIN

10 3LITHIUM CARBONATE

11 1LORATADINE AND PSEUDOEPHEDRINE SULFATE

12 1METAXALONE

13 1MORPHABOND ER

14 1NICORETTE

15 4NICOTINE POLACRILEX

16 1NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS)

17 2PAROXETINE HYDROCHLORIDE

18 1RANOLAZINE

19 1ROXYBOND

20 1TARKA

21 8VERAPAMIL HYDROCHLORIDE

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothSanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

GLYBURIDE

Drug : DIABETA

Dosage Form : TABLET; ORAL

Application Number : 17532

Country : US

Patented : No

Sanofi Company Banner

03

Fi Europe 2024
Not Confirmed
arrow

04

Fi Europe 2024
Not Confirmed
arrow

05

Fi Europe 2024
Not Confirmed
arrow

06

Fi Europe 2024
Not Confirmed
arrow

07

Fi Europe 2024
Not Confirmed
arrow
arrow
Fi Europe 2024
Not Confirmed

VERAPAMIL HYDROCHLORIDE

Drug : VERAPAMIL HYDROCHLORIDE

Dosage Form : TABLET, EXTENDED RELEASE; ORAL

Application Number : 74587

Country : US

Patented : No

blank

08

OHEMO LIFE

Morphine Sulfate

Fi Europe 2024
Not Confirmed
arrow
OHEMO LIFE
arrow
Fi Europe 2024
Not Confirmed

MORPHINE SULFATE

Drug : MORPHABOND ER

Dosage Form : TABLET, EXTENDED RELEASE; ORAL

Application Number : 206544

Country : US

Patented : Yes

blank

09

Fi Europe 2024
Not Confirmed
arrow
PPI-DAC
arrow
Fi Europe 2024
Not Confirmed

NICOTINE POLACRILEX

Drug : NICOTINE POLACRILEX

Dosage Form : TROCHE/LOZENGE; ORAL

Application Number : 90711

Country : US

Patented : No

blank

10

Fi Europe 2024
Not Confirmed
arrow
PPI-DAC
arrow
Fi Europe 2024
Not Confirmed

NICOTINE POLACRILEX

Drug : NICOTINE POLACRILEX

Dosage Form : TROCHE/LOZENGE; ORAL

Application Number : 203690

Country : US

Patented : No

blank